Abstract
The adenomatous polyposis coli (APC) gene and its expressed product are highly studied because of its role as a tumour-suppressor protein. Inherited mutations in APC lead to the condition known as familial adenomatous polyposis (FAP), which predisposes the affected individuals to colorectal cancer. Furthermore, mutations in APC are found in the majority of sporadic cases of colon cancer. There have been many published studies concerning the cellular localisation of APC, this being fundamental to our understanding of its function, but there has also been much concern over the specificity of certain commercially available antibodies to APC. Here we report that the widely used antibody APC(N15) demonstrates a strong interaction with the Ku80 subunit of the Ku heterodimer under defined experimental conditions. Based on the data presented here, we suggest that APC(N15) is not suitable for many applications used for the study of APC.
Similar content being viewed by others
Main
Adenomatous polyposis coli (APC) is a large multifunctional tumour-suppressor protein. It is central to many processes including developmental regulation and it is mutated in most cases of sporadic colon cancer. Germline mutations in APC lead to the condition known as familial adenomatous polyposis (FAP), which predisposes affected individuals to colorectal cancer (Dikovskaya et al, 2001; Fodde et al, 2001; Bienz, 2002 for reviews). Much focus has recently been placed on the cellular localisation of the protein and interaction with cellular counterparts. Such studies rely on unambiguous target protein recognition by cognate antibodies.
Ku70 and Ku80 are constituent subunits of the Ku heterodimer. This protein complex, which is located primarily in the nucleus (Bertinato et al, 2001; Koike et al, 2001), has key roles in numerous cellular processes, including DNA repair, chromosome maintenance and regulation of transcription (Ramsden and Gellert, 1998). In most instances, the Ku heterodimer is in a complex with the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs).
There are many commercially available antibodies that recognise epitopes of APC including APC(N15), which has been widely used for a number of applications (Henderson, 2000; Reinacher-Schick and Gumbiner, 2001; Zhang et al, 2001). The epitope of this rabbit polyclonal corresponds to the amino terminal 15 residues of human APC exon 1, a region identical to the corresponding mouse sequence. Manufacturers' claims suggest that this antibody is suitable for immunoblotting, immunoprecipitation (IP) and immunohistochemistry (Santa Cruz, 2000). However, the suitability of APC(N15) for immunoblotting and immunohistochemistry has been questioned (Rosin-Arbesfeld et al, 2001; Mogensen et al, 2002). We add to these concerns and present data to show that APC(N15) demonstrates a strong nonspecific interaction with the Ku80 subunit.
Materials and methods
Cell lines
SW480 cells (ECACC) were grown in DMEM/10% FBS, HCT116 cells (ECACC) were grown in McCoy's 5a medium/10% FBS.
Immunofluorescence
Cells were seeded (5 × 105 cells) in 40 mm tissue culture dishes. Cells were washed in PBS, fixed with 4% paraformaldehyde for 20 min at RT, washed in PBS before being permeabilised in 0.2% Triton X-100 for 15 min at RT. After a further PBS wash, cells were blocked in PBS–5%FBS for 1 h at RT. Cells were incubated with primary antibodies diluted in PBS–5%FBS for 30–60 min at 37°C, rinsed in PBS (× 3) for 5 min before incubation for 30–60 min at 37°C in secondary antibodies diluted in PBS–5%FBS. Following secondary antibody incubation, cells were washed (× 3) in PBS and stored in PBS for imaging using a Zeiss Axioplan 2 and LSM510 confocal microscope. Antibodies and dilutions are as follows: APC(N15) 1 : 75 (Santa-Cruz Biotechnology), Ku(p80) 1 : 50 (Oncogene).
Western blot
Whole-cell lysate was prepared (50 mM Tris-HCL, pH7.4, 100 mM Kac, 0.1% (v/v) Triton, 1 mM AEBSF, 2 μg ml−1 aprotinin, 10 μ M bestatin, 10 μ M E64, 1 UM pepstatin, 100 μ M leupeptin, 1 mM sodium ortho vanadate) and cell extracts resolved by SDS-PAGE. Gels were electrophoetically transferred onto PVDF membrane. Blots were probed with antibodies diluted as follows: APC(N15) 1 : 1000 (Santa Cruz Biotechnology, California), Ku80 1 : 200 (Oncogene, Germany).
Immunoprecipitation
Immunoprecipitation was performed essentially as described in Chan et al (2002). The lysis buffer used was the same as for Western blotting above. Silver staining was according to the manufacturer's instructions (Biorad, Hertfordshire, UK).
Mass spectrometry
In-gel protein samples were automatically digested using a Micromass MassPREP Station (Micromass, Wythenshawe, UK). MS protein analysis was carried out by Micromass using electrospray MS and MS/MS on a Micromass Q-TOF2 mass spectrometer. All data were processed automatically by means of Protein Lynx software, protein identification was achieved by analysis with ProteinLynx Global Server version 1.0.
Results
In an effort to isolate APC and its binding partners, the antibody APC(N15) was incubated with whole-cell lysate from SW480 colon carcinoma cells. SW480 cells contain a truncated version of APC of 150 kDa as a result of a stop codon caused by frameshift mutation. Protein A–agarose beads were used to pull down the antibody–protein complex allowing protein analysis by SDS-PAGE. Following silver staining, two bands of 70 and 80 kDa showed a reproducible enrichment; however, there did not appear to be an equivalent band of the expected size for APC (Figure 1). Both bands were excised, and analysed by mass spectrometry. The samples were unambiguously identified as an ATP-dependent DNA helicase class II 70 kDa subunit (Ku70) and an ATP-dependent DNA helicase class II 80 kDa subunit (Ku80) (Micromass, Wythenshawe, UK). Protein identifications were made by matching both peptide masses and sequences of the digested proteins (data not shown).
Adenomatous polyposis coli has been shown to interact with DNA (Deka et al, 1999), leading to the possibility that interaction with the Ku heterodimer may have occurred indirectly through DNA molecules with double-strand breaks. To eliminate this possibility, the IP was repeated in the presence of DNase. The removal of DNA was confirmed by running a sample on a 1% (w/v) agarose gel before visualising nucleic acid with ethidium bromide (data not shown). In the absence of DNA, Ku70 and Ku80 persistently immunoprecipitated with antibody APC(N15).
A final possibility to account for the coimmunoprecipitation interaction was that one or other of the Ku proteins was interacting nonspecifically with the APC(N15) antibody. To address this, an IP from SW480 whole-cell lysate was performed using an antibody to Ku80. The resulting immunoprecipitate was split into two and resolved by SDS-PAGE, each sample alongside an aliquot of purified DNA–PK complex (which includes Ku70 and Ku80), as positive control. One set was visualised by silver staining, while the other was transferred onto PVDF membrane and immunoblotted first with the Ku80 antibody and then APC(N15). The silver-stained gel revealed two enriched bands of 70 and 80 kDa (data not shown), identical in appearance to those pulled down by APC(N15). The immunoblot demonstrated that both the Ku80 and APC(N15) antibodies detected the Ku80 subunit (Figure 2).
Discussion
We present evidence that the widely used APC antibody, APC(N15), demonstrates a strong interaction with the Ku80 subunit component of the Ku heterodimer. This antibody is not suitable for immunoprecipitation of its intended antigen, although it is extremely efficient at affinity purifying the Ku heterodimer. As others have commented (Mogensen et al, 2002), a typical immunoblot with APC(N15) of whole-cell lysate reveals a number of intense bands between 40 and 90 kDa (one of these intense bands is Ku80), but only a weak band of the correct size for APC itself (Figure 3). Furthermore, a band corresponding to the size of full-length APC was observed on longer exposures of SW480 cells, which do not contain full-length APC. This is in accordance with Mogensen et al (2002), who detected a similar band in DLD1 cells that also express a truncated APC protein. This indicates that the full-length band observed is most likely because of a further crossreaction.
There has been some concern as to the suitability of the widely used antibody APC(N15) for immunohistochemistry (Rosin-Arbesfeld et al, 2001: Mogensen et al, 2002), although this has yet to be fully resolved. The observation that APC(N15) does not detect ectopically expressed GFP-tagged APC or microtubule-associated APC (Rosin-Arbesfeld et al, 2001) adds weight to this concern.
We looked at colocalisation of APC(N15) and Ku80 (Figure 4) and observed nuclear staining with both antibodies in SW480 and HCT116 cells. Although staining of nuclei is greater with Ku80 compared with APC(N15), it is possible that this is because of different titres of antibody. We also noted that the levels of nuclear staining with APC(N15) in SW480 and HCT116 cells are similar in contrast to the staining patterns observed using the APC antiserum raised by Nathke et al (1996). Finally, although APC(N15) detects additional material outside the nucleus, we cannot exclude the possibility that APC(N15) is detecting other proteins in addition to Ku80 (see immunoblot, Figure 3).
It is noteworthy that two reports published simultaneously, and describing the nuclear localisation of APC in SW480 cells (Henderson, 2000; Rosin-Arbesfeld et al, 2000) presented almost identical images despite one of them (Henderson, 2000) using APC(N15). One explanation could be that this presentation is fortuitous because of the abundance of nuclear APC observed in SW480 cells.
Based on the evidence we have presented here, we would suggest that APC(N15) is unreliable because of crossreactivity and is therefore not suitable for immunodetection of APC.
Summary
The adenomatous polyposis coli (APC) gene and its expressed product are highly studied because of its role as a tumour-suppressor protein. Here we report that the widely used APC antibody (N15) demonstrates a strong interaction with the Ku80 subunit of the Ku heterodimer.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bertinato J, Schild-Poulter C, Hache RJG (2001) Nuclear localization of Ku antigen is promoted independently by basic motifs in the Ku70 and Ku80 sub-units. J Cell Sci 114: 89–99
Bienz M (2002) The sub-cellular destinations of APC proteins. Nat Rev Mol Cell Biol 3: 328–338
Chan TA, Wang Z, Dang LH, Vogelstein B, Kinzler KW (2002) Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation. PNAS 99: 8265–8270
Deka J, Herter P, Sprenger-Haussels M, Koosch S, Franz D, Muller K-M, Kuhnen C, Hoffmann I, Muller O (1999) The APC protein binds to A/T rich DNA sequences. Oncogene 18: 5654–5661
Dikovskaya D, Zumbrunn J, Penman GA, Nathke IS (2001) The APC protein: in the limelight out at the edge. Trends Cell Biol 11: 378–384
Fodde R, Smits R, Clevers H (2001) APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 1: 55–67
Henderson B (2000) Nuclear-cytoplasmic shuttling of APC regulates β-catenin sub-cellular localization and turnover. Nat Cell Biol 2: 653–660
Koike M, Shiomi T, Koike A (2001) Dimerization and nuclear localization of Ku proteins. J Biol Chem 276: 11167–11173
Mogensen MM, Tucker JB, Mackie JB, Prescott AR, Nathke IS (2002) The APC protein unambiguously localizes to microtubule plus ends and is involved in establishing parallel arrays of microtubule bundles in highly polarized epithelial cells. J Cell Biol 157: 1041–1048
Nathke IS, Adams CL, Polakis P, Sellin JH, Nelson WJ (1996) The adenomatous polyposis tumor suppressor protein localites to plasma membrane sites involved in active migration. J Cell Biol 134: 165–179
Ramsden DA, Gellert M (1998) Ku protein stimulates DNA end joining by mammalian DNA ligases: a direct role for Ku in repair of DNA double-strand breaks. EMBO J 17: 609–614
Reinacher-Schick A, Gumbiner BM (2001) Apical membrane localization of the APC tumour suppressor protein and sub-cellular distribution of the β-catenin destruction complex in polarized epithelial cells. J Cell Biol 152: 491–502
Rosin-Arbesfeld R, Townsley F, Bienz M (2000) The APC tumour suppressor has a nuclear export function. Nature 406: 1009–1012
Rosin-Arbesfeld R, Ihrke G, Bienz M (2001) Actin-dependent membrane association of the APC tumour suppressor in polarized mammalian epithelial cells. EMBO J 20: 5929–5939
Zhang F, White RL, Neufeld KL (2001) Cell density and phosphorylation control the subcellular localization of adenomatous polyposis coli protein. MCB 21: 8143–8156
Acknowledgements
We thank Micromass (Dr Jonathon Coffey) for undertaking the q-TOF analysis on our behalf. Dr Gwyndaf T Roberts was supported by BBSRC (Grant number 35086). Melanie L Davies was supported on a grant from the Tenovus Cancer Research Charity (Grant number 35141).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Roberts, G., Davies, M. & Wakeman, J. Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli. Br J Cancer 88, 202–205 (2003). https://doi.org/10.1038/sj.bjc.6600732
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600732
Keywords
This article is cited by
-
Validation and application of a novel APC antibody in western blotting, immunoprecipitation, and immunohistochemistry
Medical Molecular Morphology (2018)
-
Immunopurification of adenomatous polyposis coli (APC) proteins
BMC Research Notes (2013)
-
Analysis of a panel of antibodies to APC reveals consistent activity towards an unidentified protein
British Journal of Cancer (2007)
-
Redefining the subcellular location and transport of APC: new insights using a panel of antibodies
EMBO reports (2005)